These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12708902)

  • 41. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
    Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
    Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
    Visentin GP; Malik M; Cyganiak KA; Aster RH
    J Lab Clin Med; 1996 Oct; 128(4):376-83. PubMed ID: 8833886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
    Whitlatch NL; Perry SL; Ortel TL
    Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The temporal profile of the anti-PF4/heparin immune response.
    Greinacher A; Kohlmann T; Strobel U; Sheppard JA; Warkentin TE
    Blood; 2009 May; 113(20):4970-6. PubMed ID: 19109231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
    Boonyawat K; Angchaisuksiri P; Aryurachai K; Chaiyaroj S; Ahmadi Z; Chong BH
    Thromb Res; 2014 Nov; 134(5):957-62. PubMed ID: 25204999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Look KA; Sahud M; Flaherty S; Zehnder JL
    Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
    Raschke RA; Curry SC; Warkentin TE; Gerkin RD
    Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
    Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y
    Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
    Warkentin TE; Sheppard JI; Moore JC; Sigouin CS; Kelton JG
    J Thromb Haemost; 2008 Aug; 6(8):1304-12. PubMed ID: 18489711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
    Selleng K; Warkentin TE; Sheppard JA; Greinacher A
    Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.
    Arepally G; Reynolds C; Tomaski A; Amiral J; Jawad A; Poncz M; Cines DB
    Am J Clin Pathol; 1995 Dec; 104(6):648-54. PubMed ID: 8526207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.
    Raschke RA; Gallo T; Curry SC; Whiting T; Padilla-Jones A; Warkentin TE; Puri A
    J Thromb Haemost; 2017 Aug; 15(8):1640-1645. PubMed ID: 28622439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.
    Song X; Huhle G; Wang L; Hoffmann U; Harenberg J
    Circulation; 1999 Oct; 100(14):1528-32. PubMed ID: 10510056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced Thrombocytopenia.
    Ritchie BM; Connors JM; Sylvester KW
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):282-286. PubMed ID: 26400659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
    Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
    Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.
    Pearson MA; Nadeau C; Blais N
    Clin Appl Thromb Hemost; 2014 May; 20(4):349-54. PubMed ID: 24288385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
    Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
    Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.